VALOR FOUNDATION INC. • FLORIDA CHAPTER 617 NONPROFIT • ST. AUGUSTINE, FL (SUITE B)
VETERANS CRISIS LINE: DIAL 988 THEN PRESS 1 (OR TEXT 838255)
PILLARS (d), (e) & (h) • 45 CFR PART 46 • 21 CFR PARTS 50 & 56

CLINICAL RESEARCH COLLABORATION & HUMAN-SUBJECTS REGULATORY ETHICS

Advancing rigorous, IRB-approved scientific inquiry into post-deployment veteran physiology under strict federal human-subjects protections and licensed clinical oversight.

SCIENTIFIC & REGULATORY ARCHITECTURE

PILLAR (d) & PILLAR (e) RESEARCH GOVERNANCE

VALOR FOUNDATION INC. is organized and operated for charitable, educational, and scientific purposes within the meaning of IRC § 501(c)(3). Our Articles of Incorporation establish strict statutory and clinical guardrails separating educational programming from IRB-regulated clinical research.

PILLAR (d) • INSTITUTIONAL RESEARCH COLLABORATION

IRB-Approved Studies, SBIR, VA & NIH Collaborations

Under Program Pillar `(d)`, Valor Foundation supports and collaborates with academic medical centers, independent research institutes, Small Business Innovation Research (SBIR) grant investigators, the U.S. Department of Veterans Affairs (VA), and the National Institutes of Health (NIH).

  • IRB Protocol Review: Every collaborative clinical study requires prior review and ongoing oversight by a duly constituted Institutional Review Board (IRB).
  • Ethical Veteran Study Recruitment: Facilitating voluntary, non-coercive recruitment of OIF/OEF and post-9/11 veterans into approved clinical trials investigating TBI, burn-pit pulmonary disease, HPA-axis dysfunction, and metabolic restoration.
  • Public-Benefit Scientific Dissemination: Publishing aggregate, de-identified findings in the public interest in accordance with IRS Revenue Ruling 76-296 scientific organization standards.
PILLAR (e) • INVESTIGATIONAL HEALTH OPTIMIZATION RESEARCH

45 CFR Part 46 & 21 CFR Parts 50 & 56 Protections

Under Program Pillar `(e)`, Valor Foundation facilitates voluntary veteran participation in structured investigational health optimization research examining peptides, hormonal optimization, and targeted nutritional supplementation.

  • Licensed Clinical Oversight: All medical evaluations, laboratory interpretations, and investigational or prescription protocols are ordered and supervised exclusively by appropriately licensed clinicians.
  • 45 CFR Part 46 (The Federal Common Rule): Full adherence to federal regulations for the Protection of Human Subjects, including risk minimization, equitable selection, and independent IRB oversight.
  • 21 CFR Parts 50 & 56 (FDA Human Subjects & IRBs): Documented written informed consent (`21 CFR Part 50`) and continuous Institutional Review Board supervision (`21 CFR Part 56`) for any FDA-regulated clinical investigation.
MANDATORY DISTINCTION — NO COMMERCIAL PRODUCT SALES OR UNAPPROVED DRUG CLAIMS: Valor Foundation Inc. (`1947 A1A S, Suite B, Saint Augustine, FL 32080`) does not manufacture, compound, distribute, or sell commercial peptides, research chemicals, pharmaceuticals, or dietary supplements on this website. Discussions of peptides, hormonal optimization, or nutritional compounds under Pillar `(e)` refer strictly to clinically supervised, IRB-governed research participation and evidence-tier education—never a promise of treatment, cure, or commercial sale.
FEDERAL & INSTITUTIONAL SAFEGUARDS

HUMAN-SUBJECTS & SCIENTIFIC COMPLIANCE MATRIX

Regulatory Standard Statutory / Federal Citation Application Across Valor Foundation Programs
Federal Policy for the Protection of Human Subjects 45 CFR PART 46 Governs all federally supported or Common Rule-aligned human-subjects research under Pillars (d) and (e), requiring independent IRB approval, risk-benefit balancing, and data privacy protections.
FDA Protection of Human Subjects (Informed Consent) 21 CFR PART 50 Requires comprehensive, non-coercive written informed consent disclosing study purpose, investigational status, alternative options, potential risks, and the absolute right to withdraw at any time without penalty.
FDA Institutional Review Boards (IRB Governance) 21 CFR PART 56 Mandates initial and continuing review of clinical research protocols, adverse-event reporting, and independent safety monitoring by a registered Institutional Review Board.
IRC § 501(c)(3) Scientific Research in the Public Interest 26 U.S.C. § 501(c)(3) Ensures all research collaborations (SBIR, VA, NIH, academic partners) serve the public interest rather than private commercial exploitation, with strict conflict-of-interest recusal by any interested director.
Non-Partisan Policy Education (Pillar h) ARTICLES § PURPOSE (h) Authorizes non-partisan educational briefings on post-deployment metabolic health, PACT Act toxic exposures, and TBI science while prohibiting political campaign intervention and substantial legislative lobbying.